Johnson & Dugan

Kartos Therapeutics Inc, based in Redwood City, CA, is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapeutics aimed at significantly improving the lives of cancer patients. Their lead investigational drug, navtemadlin (KRT232), is a potent and selective oral MDM2 inhibitor designed to provide new treatment options for patients with selected solid tumors and hematological malignancies. The company focuses on advancing its research through active clinical studies and is committed to the science of cancer treatment, emphasizing the importance of targeted therapies. With a mission centered on breakthrough therapies, Kartos Therapeutics is at the forefront of innovation in the fight against cancer. Generated from the website

Setting goals for your financial future is important. Of course, with unpredictable markets and the unexpected twists and turns that come with life, getting to those goals can sometimes feel difficult. As an Ameriprise financial advisor serving clients in the Redwood Shores, CA area, Andrew Andrikopoulos will take the time to understand you and your goals, as well as those changing markets, and can help you confidently focus on the future. If the path seems long and uncertain, a carefully mapped approach is the best way forward. We're here to help you stay focused today, so you can reach your goals tomorrow. The comments displayed are not verified, may not be accurate and are not necessarily representative of our client experience.